Loading...

Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial

PURPOSE: To examine the association of baseline body mass index (BMI) with the risk of recurrence or death in postmenopausal women with early-stage breast cancer receiving adjuvant tamoxifen or letrozole in the Breast International Group (BIG) 1-98 trial at 8.7 years of median follow-up. PATIENTS AN...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Ewertz, Marianne, Gray, Kathryn P., Regan, Meredith M., Ejlertsen, Bent, Price, Karen N., Thürlimann, Beat, Bonnefoi, Hervé, Forbes, John F., Paridaens, Robert J., Rabaglio, Manuela, Gelber, Richard D., Colleoni, Marco, Láng, István, Smith, Ian E., Coates, Alan S., Goldhirsch, Aron, Mouridsen, Henning T.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Clinical Oncology 2012
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3488270/
https://ncbi.nlm.nih.gov/pubmed/23045588
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.40.8666
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!